Ex parte REINHARD et al. - Page 8




                 Appeal No. 1998-2183                                                                                                                   
                 Application No. 08/529,195                                                                                                             


                 the following matters.                                                                                                                 


                          As evident from our assessment of the applied art above,                                                                      
                 there is no prior art teaching of the claimed feature of a                                                                             
                 protective cap of soft material covering an injection needle                                                                           
                 so that the needle pierces the protective cap and is thereby                                                                           
                 sealed. Should the examiner be aware of such a teaching, the                                                                           
                 examiner may determine it appropriate to reassess the                                                                                  
                 patentability of the claimed subject matter.  Starting with                                                                            
                 the knowledge in the art of glass syringes with filling                                                                                
                 volumes of less than 5 ml, a determination should be made as                                                                           
                 to whether the disclosures of Sudo and Kimber (U.S. Patent No.                                                                         
                 5,135,514, of record) would have been suggestive of replacing                                                                          
                 glass with a cyclic olefin compound or polypropylene,                                                                                  
                 respectively.   While glass may have been known to be used6                                                                                                              
                 with prefilled, disposable syringes for injections of less                                                                             
                 than 5 ml (specification, pages 2 through 4), it does not                                                                              
                 appear that either of Declarants Spallek or Spingler were                                                                              


                          6Appellants make reference to preferred cyclic olefin                                                                         
                 copolymers and glass-clear polypropylene (specification, pages                                                                         
                 9 and 15).                                                                                                                             
                                                                           8                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007